ARTICLE | Company News
Variagenics, St. Jude Children's Research Hospital deal
July 29, 2002 7:00 AM UTC
VGNX licensed from St. Jude a patent application covering the use of CYP3A5 genotyping technology to develop diagnostic kits predictive of drug response based on variable expression of CYP3A5. Under t...